Jump to content

Tizanidine: Difference between revisions

From Pharmacopedia
[unchecked revision][unchecked revision]
Dedupe migration per interface-claude 2026-05-20: Muscle Relaxants (CNS-acting) merged into canonical Muscle relaxants. Member retagged.
Tier 1 taxonomy consolidation: removed redundant Category:Muscle_Relaxants (canonical already present)
Line 32: Line 32:


[[Category:Muscle relaxants]]
[[Category:Muscle relaxants]]
[[Category:Muscle_Relaxants]]

Revision as of 17:02, 21 May 2026

Muscle relaxant
Tizanidine
Zanaflex

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Interactions

Pharmacogenomic + mechanism interactions2 edges
Pharmacokinetic mechanismSubstrate / metabolism relationships from primary literature
Enzyme:CYP1A2 substrate major Primary 80 / 100
FDA Drug Interactions Table: sensitive index substrate of CYP1A2.
Inferred from pharmacokinetic dataMaterialised by the inference engine; provenance shown per row
Fluvoxamine pk raises via CYP1A2 Inferred 72 / 100
Fluvoxamine inhibits CYP1A2 (inhibitor_strong, intensity 90); Tizanidine is a substrate_major of CYP1A2 (intensity 80). Derived: Tizanidine exposure raised.
Inferred via Enzyme:CYP1A2 (exposure raised)

Patient experience

No patient-experience reports yet.

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Classes
Muscle relaxant
Common uses
Pharmacy
Pharmacology
Purported mechanism
Alpha-2 adrenergic receptor agonist